HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

AuthorsLaurence Bouillet, Isabelle Boccon-Gibod, Denise Ponard, Christian Drouet, Jean Yves Cesbron, Chantal Dumestre-Perard, Nicole Monnier, Joel Lunardi, Christian Massot, Anne Gompel
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 103 Issue 5 Pg. 448 (Nov 2009) ISSN: 1081-1206 [Print] United States
PMID19927548 (Publication Type: Case Reports, Letter)
Chemical References
  • Adrenergic beta-Antagonists
  • Bradykinin Receptor Antagonists
  • Complement C1 Inhibitor Protein
  • icatibant
  • Bradykinin
Topics
  • Adrenergic beta-Antagonists (administration & dosage, therapeutic use)
  • Adult
  • Bradykinin (administration & dosage, analogs & derivatives, therapeutic use)
  • Bradykinin Receptor Antagonists
  • Complement C1 Inhibitor Protein (genetics)
  • Female
  • Gene Deletion
  • Hereditary Angioedema Type III (drug therapy, genetics)
  • Humans
  • Injections, Subcutaneous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: